FDA approves Crosstrees' surgical device
Last Updated: 16:00 September 19, 2013
Boulder-based Crosstrees makes spinal-surgery devices. Its PVA Pod System uses a polymer material to help deliver bone cement to a vertebral fracture during surgery. The Crosstrees treatment does not require a device to be implanted in the spine.
A study conducted on 135 patients in the United States, China, Venezuela and Belgium showed the new device to help reduce pain and to lower new fracture rates, according to Crosstrees.
An estimated 700,000 people in the United States have vertebral compression fractures annually, according to the National Osteoporosis Foundation.
Crosstrees was founded in 2003. The company is privately held. It is funded by Ascent Biomedical Ventures, Rho Ventures and private individuals, according to the press release. Venture capitalists in 2008 put $12.03 million into the company, according to venture capital information compiled quarterly by PriceWaterhouseCoopers LLP.
FDA approval is required for all medical devices sold in the United States.
More breaking news...
Dillard's 'price' case starts Wednesday
Vail Resorts reports loss for fiscal Q1
Business hall of fame seeking nominations
Each year the hall identifies five to eight businesspeople who exemplify business, cultural and philanthropic initiatives that